-- Solomon Moshkevich, President of Clinical Diagnostics, on May 01, 2026, sold 3,405 shares in Natera (NTRA) for $693,560. Following the Form 4 filing with the SEC, Moshkevich has control over a total of 142,295 common shares of the company, with 142,295 shares held directly.
SEC Filing: